Ignite Creation Date:
2025-12-24 @ 10:01 PM
Ignite Modification Date:
2025-12-25 @ 7:37 PM
Study NCT ID:
NCT04878432
Status:
TERMINATED
Last Update Posted:
2025-10-16
First Post:
2021-05-05
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
STIMULUS MDS-US : Sabatolimab Added to HMA in Higher Risk MDS
Sponsor:
Novartis Pharmaceuticals
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2022-03-17
Start Date Type:
ACTUAL
Primary Completion Date:
2023-10-26
Primary Completion Date Type:
ACTUAL
Completion Date:
2024-09-01
Completion Date Type:
ACTUAL
First Submit Date:
2021-05-05
First Submit QC Date:
None
Study First Post Date:
2021-05-07
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2025-06-17
Results First Submit QC Date:
None
Results First Post Date:
2025-07-31
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
2025-07-31
Disp First Post Date Type:
ACTUAL
Last Update Submit Date:
2025-10-08
Last Update Post Date:
2025-10-16
Last Update Post Date Type:
ESTIMATED